Table. 4.

Table. 4.

Median survival times of patients diagnosed with ICC in SEER registry 18 (2000–2017)

Variable Median survival time (mon)
Sex
Male 8
Female 8
Race
White 8
Black 7
Other 8
Therapy
Surgery with chemoradiotherapy 33
Surgery with chemotherapy 25
Surgery with radiotherapy 30
Surgery alone 32
TNM staging
T1 12
T2 13
T3 8
T4 8
TX 5
Lymph node removal surgery
None 7
Biopsy or aspiration of regional lymph node 13
One to three regional lymph nodes removed 30
Four or more regional lymph nodes removed 28
Year
2000–2006 12
2007–2011 9
2012+ 6
Age group
< 60 years 9
60–69 years 8
≥ 70 years 6

ICC, intrahepatic cholangiocarcinoma; SEER, Surveillance, Epidemiology, and End Results Program.

Ann Hepatobiliary Pancreat Surg 2022;26:235-43 https://doi.org/10.14701/ahbps.21-173
© 2022 Ann Hepatobiliary Pancreat Surg